Magnera Corporation (MAGN) Earnings Call Transcript
February 5, 2026
Earnings Call Speaker Segments
Thanks, operator, and I appreciate all of you being here on Magnera's First Quarter 2026 Earnings Call. With me today are Magnera's Chief Executive Officer, Curt Begle, along with our Chief Financial Officer, Jim Till. Once we finish our prepared remarks, we'll open things up for a question-and-answer session. So that as many people as possible get a chance to speak, please keep it to one question plus a short follow-up, and then rejoin the queue if you have anything further. A couple of quick notes before I pass things along; today's press release and the earnings call presentation are posted on our website, magnera.com, under Investor Relations. You're also welcome to visit ir.magnera.com directly, where you can look through the investor presentations from our recent conference attendance. And finally, our annual report and proxy statements have been filed with the SEC, and you'll find those on our website under Investor Relations and Financials. As noted on Slide 2, we'll be covering certain non-GAAP financial measures during this call. Reconciliations of those measures to the most directly comparable GAAP financial measures appear in our earnings press release as well as in the appendix of the presentation that's available on our website. Also, a reminder that certain forward-looking statements will be made. Such statements reflect management's expectations and beliefs about future events affecting the company and are therefore subject to risks and uncertainties. Actual results or outcomes could differ materially from what's expressed or implied in our forward-looking statements. Among the factors that might cause results or outcomes to differ are those in the company's latest SEC filings and our news releases. Such statements speak only as of today, and we undertake no obligation to update them. At this point, I'll hand the call over to Magnera's CEO, Curtis Begle.
Robert, thank you. Good morning, everybody, and I'm glad you could join us today. It's a pleasure to take you through what we delivered in Q1 and to highlight the momentum we're carrying into 2026. During this update, I'll discuss our financial performance, spotlight key innovation efforts designed to reinforce the differentiated mix of our portfolio, and describe how our business excellence journey aligns with emerging macro trends. Beginning with the sequential earnings improvement over Q4 — it came in right where we expected and backs our 2026 adjusted EBITDA guidance of 9% growth, while synergy realization and Project CORE transformation programs are both on track as planned. It's worth pointing out that although there are concerns about consumer spending related to inflation, our customers continue to demonstrate resilience, and they're still seeking the essential goods we provide. In Magnera's Rest of World segment, the improvement in earnings stems from a strong emphasis on addressing our cost base in highly competitive end markets, alongside an increase in the share of consumer solutions within our portfolio. Volume gains from organic growth in North America helped counterbalance the decline we had anticipated year over year in South America, which resulted from competitive import pressure originating in Asia. There are open inquiries in multiple countries related to antidumping issues and potential retaliatory measures. Looking ahead to the next several quarters, we expect South American earnings to remain stable, since we will be lapping the prior-year comparison during the third quarter. We've enhanced the mix within our personal care segments by meeting what the biggest consumer products firms require and by broadening our premium offerings for private label uses. Our consumer solutions keep performing well thanks to sustained spending on sustainability infrastructure across Europe and Asia. Having worldwide scale gives us a foundation that helps us handle energy efficiency more effectively as productivity rises. I've directed the team covering the Americas to step up operational gains in North America via focused investments and operational excellence, which will open growth possibilities in platforms where demand outstrips supply. The South American markets are stabilizing just as we expected, which shows in the supply chain alignment we share with our customers. Now let's turn to innovation on Slide 7. Let me point out how our work is going to improve the mix of our business once we get to 2026 and the years after that. Not long after Magnera got off the ground, we made a deliberate choice to put our resources behind initiatives that fit within the larger plan we had for becoming a leader on cost among product makers in the markets we picked. Being the partner customers trust for solving their toughest consumer problems is what drives us. A handful of our top innovations across two categories are shown in the presentation materials, and the first of those categories is transformational by design. These innovations take more time before their full potential shows up, but they tackle important needs in the end markets. We labeled a second category as either step-by-step enhancements to products we already have or bringing something we already invented into a market that is new. During the prior quarter, we introduced a game-changing advancement in barrier protection designed for health care uses; this patented technology provides the smooth repellency standards that medical practitioners need while removing any reliance on PFAS substances. Beyond simply tackling end-of-life material concerns, this innovation also supplies the essential performance the final user demands. One more thrilling development to mention: the progress we've made on a sophisticated materials answer that extends how long batteries last and accelerates recharge times. As lithium-ion batteries grow in tandem with vehicle electrification and escalating defense needs, we developed a product that qualifies as a contender for a government grant supporting domestic supply chain objectives tied to vital national security initiatives. Next, I want to talk about the kinds of innovation Magnera can deliver by drawing on its existing intellectual property and platform strengths, all focused on making today's products better. With our Kamisoft platform, softness takes a meaningful leap forward, and barrier performance along with tensile strength stay just as strong. We launched this offering in North America, then carried the same platform into our other regions. Sales came in at $15 million during the prior year, and as we head toward 2026, we expect growth in the mid-single digits. These advantages show up for consumers regularly in personal care items sold under brands as well as private labels. Before I finish my opening remarks, I want to be clear about how we are winning in the market. In Q1, our technology for premium hard surface disinfectant wipes proved its value during a flu season that ran higher than usual. Being able to meet shifting customer supply needs showed how flexible we are and how much our regional supply chain brings, which drove solid expansion in the Americas. Beyond that, we were able to handle increased demand for premium private label baby wipes, consumer wipes and dispersible wipes. European infrastructure growth gave us a second bright spot, enabled by our solid standing in projects tied to essential utility investment and maintenance. Because Europe has made infrastructure a priority so that critical utilities and data cables keep running without interruption, we've put operational improvements in place to raise efficiency and meet rising demand. To wrap up, our Geca Tape brand—which provided essential shielding from harsh environmental factors both above ground and beneath the sea for high-voltage cable uses, as well as for wind and solar energy build-outs—also turned in solid improvement during the quarter. Now let's turn to Slide 10. We have laid out strategic priorities that are unmistakable, grounded in discipline, and deliberately crafted to set the company up for durable success over the long haul. At the core of what we're doing is a pledge to make our worldwide cost base stronger, making certain we run with the kind of efficiency, scale, and competitive edge needed to deserve a winning position in the markets we serve. Equally critical, we are concentrated on product leadership—encouraging considered, teamwork-driven innovation throughout the organization and alongside our customers. Combining sharp knowledge of the market with strong technical skill, our goal is to build distinctive offerings that deliver lasting worth and strengthen where we already lead. Last, we're pushing forward a broad collection of commercial excellence programs so we can completely capture the benefits of what we sell, what we're able to do, and where we stand in the market. With careful execution, a tighter emphasis on the segments that matter most, and deeper involvement with customers, we'll make the biggest difference in the areas we pick for competing and expanding. The path we've set was designed to build on the strong footholds we hold in important markets, as shown on Slide 11. We intentionally keep our range of products balanced, which lets us remain financially stable across all types of economic cycles. We have not lost confidence in our capacity to meet the financial guidance we set for the full year. Work on our optimization initiatives is progressing well, and we keep nurturing an innovative culture that matches what we have promised our customers, while also delivering the dependable financial results our investors look for. With that, I'll wrap up my opening comments and ask Jim to walk through our financial performance in detail.
Thanks, Curt, and hello everybody. Let's look at the financial highlights on Slide 12. Like Curt mentioned before, our earnings for the quarter came in as expected. That result shows the ongoing discipline and execution from our worldwide teams, who achieved significant cost savings, moved productivity programs forward and further refined our product mix throughout the company. Significantly, we made considerable strides on Project CORE during the quarter, which puts us in position to capture earnings gains as we keep optimizing our worldwide operations and bring our cost base in line with long-term demand patterns. Sales for the quarter totaled $792 million, since momentum in our consumer solutions categories was outweighed by softer results in Latin America along with persistent widespread market weakness in Europe. Even with those challenges, our team stayed committed to disciplined pricing, portfolio management and keeping costs in check. Adjusted EBITDA came to $93 million for the quarter, unchanged from the prior year on a constant currency basis, as gains from synergies and cost cutting efforts balanced out the effect of weaker demand in Europe and South America. Now let's move to segment performance, starting with Americas on Slide 13. During the quarter, the Americas division posted 2% organic volume growth, mainly fueled by robust demand in our wipes and adult end markets. Those increases demonstrate both the durability of our core categories and how well our commercial execution is working. As we've mentioned on earlier calls, heightened competitive pressure that started in the second quarter of fiscal 2025 created challenges for the South America baby business. Reported revenues also took a hit from contractual pass-through of reduced raw material costs, which lowered revenues without significantly affecting profitability. Adjusted EBITDA for the Americas fell by $3 million versus the prior year; volume and product mix pressures in South America were mainly responsible for that drop. Although this performance doesn't please us, we stay confident in our capacity to enhance results over the rest of the year. Under Project CORE, our teams are actively carrying out a variety of targeted efforts aimed at boosting efficiency and optimizing the regional footprint. We anticipate that these efforts, together with continued synergy delivery and a strong focus on operational excellence, will drive margin recovery in the quarters ahead. Now shifting to the Rest of World division on Slide 14. We saw revenues decline year-over-year during the quarter, as momentum in our Asia healthcare business was outweighed by sustained general market weakness in Europe and the pass-through of reduced raw material costs. Although top line conditions in Europe remain difficult, the region's earnings resilience gives us encouragement. For the Rest of World segment, adjusted EBITDA rose a notable 9%, reaching $35 million. That gain speaks to how we keep making headway with tight cost control and capturing synergies, even as we concentrate on bringing differentiated offerings to end markets where profitability looks appealing. What this division just posted makes clear how much we gain from our strategic emphasis on running efficiently and refining the portfolio. Now let's shift to how we're prioritizing capital allocation, which you can see laid out on Slide 15. Across the trailing 4 quarters, free cash flow came to $97 million, which works out to a free cash flow yield of roughly 18%, calculated using market capitalizations as of the quarter's close. The cash we're generating so strongly speaks to how solid and durable our earnings are, and it shows how carefully we deploy capital. When the quarter ended, we held about $550 million in available liquidity. Looking ahead a bit, reinforcing our balance sheet stays our top capital allocation aim, since we've pledged to bring leverage down consistent with the capital allocation framework we've stated, as we push toward our leverage ratio target of 3x. Being disciplined in this way keeps our financial flexibility intact while setting the company up to create value over the long haul. Backing up that pledge, we paid down $27 million of debt that was outstanding during the quarter, and we anticipate repaying roughly $100 million across the fiscal year, all while delivering sustained, attractive returns to shareholders over time. That wraps up my financial overview, and I'll hand things back to Curt.
Appreciate that, Jim. So Magnera has now formally begun year two since we launched, and I want to express gratitude to our great staff for being ready to take on difficult tasks and carry out our tough game plan. Even with a shifting macro backdrop, we widened margins by staying focused on running things well and turned in a solid quarter financially; through growth in earnings and generating plenty of free cash flow, we're dedicated to boosting value for those with a stake in the company. We know exactly what matters most: running operations at a high level, keeping the balance sheet solid, allocating capital with care, and pursuing strategic investments along with chances to grow; by doing these things, we're set up to lock in shareholder value over the long haul while staying nimble in a worldwide marketplace that's highly competitive. Operator, could you please make the line available for questions.
Curt, I'd like to kick things off. You described certain possible interventions — antidumping actions and countermeasures — that are currently under review. Could you discuss the likely timeline for them? My guess is that the bulk of this relates to South America. Also, have you noticed any shift in how competitors are behaving? Beyond that, in a related vein, several of your customers have been merging or forming partnerships in this market. At this point, has that altered any of the discussions?
Gabe, I appreciate you being on the call this morning and for raising the question. Let me begin with where things stand on antidumping: Brazil has legislation as well as proposals in play, and our expectation is that around May, those will reach some kind of resolution. The dialogue we're hearing leaves us encouraged. Measures targeting polyolefin materials entering the region were recently put in place, and now that approach has been proposed and broadened to cover nonwoven materials — which, once again, are what we produce and deliver within that country. Regarding conversations with customers, we mentioned how the talks we've been having have steadied, along with the supply chain alignment we share. As we've shifted portions of the portfolio, what has encouraged us is that higher-end applications in the region are scaling up. Another South America development: adoption rates for adult incontinence are climbing. Government subsidies have played a role in driving that, so those rates keep rising. Given the quality of goods now supplied in that region, the impact mirrors what has happened in places such as the U.S. and various European countries. That leaves us encouraged, and we're already witnessing a portfolio shift — historically, as we've noted, South America was mostly baby products for us. That segment now represents 20% of the overall portfolio for South America alone, so we expect continued mix change and improvement across our product lines. Gabe, I believe your remaining question concerned some of the customer — or rather, partnerships among our customers. Is that what you meant? Could you clarify?
Yeah. Some of your customers have recently gone through mergers, or they've formed cross-border partnerships of some sort; so I'm wondering whether that has improved or altered the way you talk with them, and maybe...
Yeah. Honestly, I've consistently seen that as something quite favorable for us, given how we're scaled globally and given the ties we maintain with essentially all the customers operating in the markets we cover. So if anything, we look at it as a bigger opening to push innovation further and help them drive efficiencies in their supply chain. And so, once again, we keep a very tight connection with those customers. Naturally, conversations are happening. There's only so much you can accomplish before those 2 organizations actually finalize things; however, a few of those customers have lately announced plans to either combine, merge or acquire, so we maintain that close contact with them and also track where their growth is happening, right, where they're directing their own investments, whether that's adding capacity or simply recapitalizing assets they already have. So we follow that closely too. So historically, we've regarded it as something very favorable. And today, with the bandwidth we've built within the company and how diverse the portfolio is, we get a better chance to hold a seat at the table and genuinely figure out how to meet their needs. Look, every one of them wants opportunities for cost innovation, but they also want the innovation side — standing out on the shelf; and that's truly where the bulk of our work goes, through our innovation team and commercial excellence team, so we remain ahead of them.
Got it — so it's more about upside, then. I just want to make sure I understand one thing: you mentioned that adult incontinence is nearing 20% of the portfolio, with the decline specifically happening in South America?
That's right. As you may remember from some of the historical details we've shared, it sits roughly within our Personal Care segment — that segment accounts for 47% of our total enterprise — and Personal Care consists of adult, fem, baby, and then healthcare. Globally, for us, it's essentially been an even 50/50 division between adult and baby, and from an adult standpoint that has risen considerably over the last 5 years. For us, the laggard has been South America, where baby has been the primary piece and adoption rates tied to adult inco have been lower. So with that South American portfolio now climbing to 20%, my expectation is that across the next 3 years to 5 years we'll see a very comparable 50/50 division; and then, in the Rest of the World across some of our more mature markets — North America, Europe, for example — I'd expect that division to shift from 50/50 toward 60/40. Making an adult incontinence product requires the same amount of material as 3 to 4 baby diapers. That's why we keep leveraging our platforms, since they're the same platforms, the same materials, the same demands when it comes to discretion, form fit, and function. And on top of that — once again — there are major efforts focused on making sure we can keep supplying our customers with the right fem care application products so that segment grows too. So we're encouraged by what we're seeing, once again, in South America — and honestly it may be moving faster than I would have expected a couple of years ago.
Understood. I'd like to ask — a few of the companies we cover have already brought up weather, and I'm aware that a fair number of your facilities are located in the corridor that some of these storms passed through. So was there any effect? This is really a short-term question, but any effect from that, and how should we be thinking about it?
Yes. To put it mildly, this has been a fascinating winter. I believe this marks the first occasion when we had that many locations genuinely hit by the storm. And on top of that, our customers got hit too; so when it comes to demand dynamics over the long run, nothing has changed versus what we'd anticipate for the remainder of the year. But luckily for us, our teams did a great job planning ahead, executing the proper shutdowns — with safety as our #1 priority across everything, given our employee base and what our core values are — and it amounted simply to call-offs affecting our employees. So essentially all of our facilities in North America got hit during the storm's first wave. The way we've best estimated it, roughly 10% of our shipping days in North America were affected. We'd anticipate some catch-up across the rest of this quarter and into the following quarter, though we'd expect a modest effect when it comes to shipments and timing, but we would recover the overhead absorption as we've ramped back up. And then with the latest storm that hit North Carolina — as you're aware, when you look at the map and at our sites, we have a fair amount of concentration in North America; beyond that, we also have quite a few customers in that region. But luckily, I take pride in what the team has managed to achieve in getting the lines fired back up and getting product out the door. I think — and we've not heard from our — any significant disruptions when it comes to supply chain logistics. But I'd guess that as store shelves keep getting replenished and some of our customers ramp their inventory back up, we'll keep watching and managing overall freight availability and logistics. Luckily for us, a large share of our customers are pickup. So we're collaborating with them on figuring out the best routes and getting those products to them. But once again, this is a situation where we weren't letting customers down because we were unable to supply product to them. It's simply going to come down to managing their inventory, store shelves, and so on, and continuing to take care of them the way we always have.
Curt, over on Wall Street, it seems like a number of investors got pretty enthusiastic regarding January's PMI increase. So I'm wondering — when you take a look throughout your portfolio, is there a lot of proof showing up of demand that's getting better underneath, or of restocking picking up, now that we've turned the page from December to January?
Kevin, I appreciate you being on the call. It's good to hear from you. You and I, I believe, have discussed destocking and restocking before, and I tend to steer clear of those subjects, since from where we sit, staying on a short cycle with our customers is what we aim for. That said, broadly speaking, we've seen demand trends similar to what you'd anticipate, especially in North America. So, as we said during the call, growth has occurred for us in North America. Our expectation is that it keeps going, and we built that into the guide. Europe remains somewhat of a worry, specifically when it comes to the broader demand picture, though we had already aimed our guide at minus 3% for that region. I believe it came in at minus 5% for the first quarter. We'll keep watching it and do what needs to be done. Still, I won't start celebrating and declare that demand is going to be incredibly strong. That said, the same signals that perhaps a few consumer products companies are talking about are being seen — or experienced — by us too, and that would be a good development. For our part, though, it's about staying disciplined, remaining near our customers, and being prepared to step up when they require more product. So we'll keep an eye on it. Optimistic, definitely, but at this stage we aren't factoring that into our outlook at all.
Got it. Then for my second question, I'd like to hear how Project CORE is progressing — perhaps walk us through what's been accomplished to this point, along with what comes next or which milestones we ought to keep in mind?
Sure, I appreciate you asking that. So regarding Project CORE, we touched on it briefly during the call, and I've felt really good about how our teams around the world have carried it out. Like we've said previously, every region felt the effects, and we deliberately zeroed in on places where supply-demand dynamics had grown more stretched out in connection with the platforms we serve. To recap, among the spun bond technologies within our system, we chose to direct investment toward particular lines serving higher-end applications, while also doing what's needed to take out a portion of capacity from our system, which once more helps us organically reshape things toward what should be stronger utilization rates across the globe. We saw a modest gain during Q1, which matched our expectations, and that should keep building through the rest of the year — a fair number of moves are happening this quarter that will begin delivering some of those gains, then get blended in across the following 2 quarters. So it remains very consistent with what we'd projected, somewhere between $15 million and $20 million in benefit. Some of our actions have been completed right on time and according to plan, with a minor slippage on a few others, though nothing meaningfully off from the guidance we've already given. Still, from our standpoint, there are particular areas and particular platforms within our network where I'm urging our teams to generate additional productivity, since utilization rates are running considerably tighter than what we've seen in the past. So we'll keep watching that closely. As for the broader set of Project CORE-related programs, everything is right on track and fully consistent with the guidance we issued.
Great. And for my final question, if that's alright. Turning to Slide 11, there's a helpful overview of the portfolio, and essentially 6 categories are shown there. I'd love to hear your thoughts on the outliers — perhaps shed some light on where the strongest positive growth is coming from, and conversely, whether any areas seem to be underperforming right now or present room for improvement as we move through the year. Based on what you said earlier, my guess is adult falls into the positive bucket; but any extra detail within that framework would be appreciated.
Yeah. Look, I'd also emphasize that examining things by segment or region matters too; so in North America specifically, we're seeing some favorable effects tied to the innovation we've brought on the baby side; and when you check store sales figures across U.S. markets, baby has risen a bit. So that's very low single-digit growth, yet adult keeps building momentum. Wipes, as we've discussed, represent a fantastic enterprise or franchise for us within the portfolio, especially when you consider certain proprietary technologies, and Kevin, you got to view it at our Mooresville site on one of your visits — that Spinlace technology and that proprietary technology has truly built up momentum, and we've managed to grow alongside the market and support our customers as they expanded in those areas. On the infrastructure side, we called out Europe during this call. That's a region where there's a good business mix. It's a solid niche application for us. But looking at North America, we also have a robust TYPAR brand, and we keep discovering ways to develop that portfolio by adding some complementary products in that space. What I'd add is that on the home food and bev side, this is a really strong position that the historical Glatfelter business had held. And so a major focus there, as we've mentioned previously, has been qualifying other materials, identifying compostable solutions for our customers and the advantages we can deliver to them too. And so that business, I'd call stable. The team has done a great job locking in the right contracts, the right business mix that we want to operate; and we all hope for cold season, so people drink more tea and coffee. But overall, that business is quite stable, I'd say, since a big concentration sits in Europe — it's not really declining in any major way, but it's more restrained than what we'd see elsewhere around the globe. And finally, healthcare, being comparatively small relative to the total portfolio, is where we've recently launched our gowns and drapes and removed PFAS materials. We believe there's not just a capacity to safeguard the business we already hold in that market, but possibly also to grow it, whether via taking share or from end users pushing for improved options when it comes to PFAS-free materials. And beyond that, within every region there are certain outliers that, generally speaking, I'd describe as somewhat more restrained. We mentioned baby in South America along with the competitive strain coming from Asia and other imports. No matter the outcome on the antidumping measures, from our standpoint, we have definitely discovered stability in that region, and the talks with customers plus our capacity to provide local supply and respond quickly have at least helped reinforce some of the dialogue we've had with them; but even more significantly, it's the conversation about how we shift further toward certain innovative products that traditionally haven't been as common in that region as what we've seen elsewhere; and our team in Asia keeps doing a good job of landing the right business for those lines, even though it's comparatively small relative to our overall business, a profitable business, and the team also does a great job supporting other regions, not just with innovative products, but with best practices throughout the system. So once more, without going too far into certain outliers in the product mix, broadly speaking, we feel good about most of where we stand regarding the portfolio. I could discuss specific applications that are fairly small and immaterial, which we keep assessing from a portfolio perspective. But broadly, I hope that gives you a bit of a sense. Yet Europe remains soft, as you've heard from other major players. The U.S. is displaying encouraging green sprouts, South America is stabilizing, and Asia Pacific remains stable.
When it comes to fiscal 2026, does your assumption for volume growth remain unchanged at flat? And what are your views regarding volumes in 2027, if you have any?
Roger, we appreciate you being on the call. It's nice to hear from you; regarding '27, we won't be offering any comments. What I think we can do is examine the longer-term dynamics of growth. And as we move through the year toward our guide, perhaps we'll give a bit more color on that; but I'm not sure, Jim, whether you'd like to — we began this year with volumes that are flattish, and our expectation was that Europe would be somewhat down, approximately 3%, with North America somewhat positive to help counterbalance that; and then what we'd see in the back half, or the final 2 quarters of our fiscal year, is entry into somewhat more normalized comps for South America. So overall, we continue to expect volumes that are flattish; and remember, Roger, we've undertaken certain deliberate efforts concerning where we wish to compete, where we're putting our weight, when it comes to our commercial excellence programs. And some businesses might not be a long-term fit within our portfolio — whether because there isn't a path for us to be the right competitive set, but even more crucially, because they need to have the right growth dynamics for us over the long term; so once again, we're being selective to ensure that, again, we capture the value for the products we supply and serve our customers with, but that will have an effect given some of the actions we've taken on CORE.
So when we look at the fiscal 2026 EBITDA guidance compared with pro forma fiscal 2025, which includes Glatfelter, would you say the biggest things behind that growth are cost savings and merger synergies? Or could something else also be pushing that improvement?
Right. From a mix perspective, I'll say a few words, since that's clearly something we've been focused on. And — I've been doing a lot of the talking here. Jim, I'll hand it over to you on the synergies side.
Right, thanks Roger. To pick up on your final question — yes, we're basically working off the assumption that volumes stay flat. So when it comes to what pushes growth in 2026, it really comes down to two things: getting those synergies realized, plus the Project CORE initiatives, which is what we walked through on our previous call.
Roger, understood. Last thing from me — wondering if you could elaborate more on the remaining pieces within fiscal 2026 free cash flow, like working capital moving in or out, which I believe you described as roughly neutral previously, plus cash taxes and anything else?
James, yes, yes. What we aim for — our consistent aim is working capital staying level. So when you map out your free cash flow bridge, sitting at the $395 million midpoint, $135 million allocated to cash taxes — pardon me, to interest, $80 million going toward integration costs and taxes, and CapEx also at $80 million; that brings us to approximately $100 million at the midpoint.
Building on a few of those innovation-related points you raised — could you give us, at least directionally, what the margin profile looks like for these innovative offerings, and whether they're proprietary items or more commoditized ones? And then, would these innovative products take business away from any others in the portfolio?
Sure, that's a great question. There are 2 distinct categories of things we do together with our customers. The first is safeguarding some of the current business by way of innovation, and identifying ways to deliver value to our customer — possibly through a cost savings opportunity — while also creating a margin up opportunity on our end. The second thing we examine is whether this is a new feature or benefit inside a particular product; and we've managed to launch some of those too. And in the past, Edward, we would — we anticipate, clearly, something above our average margin. So that could fall anywhere from the mid-teens to 20-plus, depending on how unique the application is, which materials are available and used in the product itself, but even more critically, the collaboration we have with our customers. So once again, we'll keep finding ways to help our customers drive efficiencies through cost competitive applications and sharing in those savings. But as far as we're concerned, we expect innovation to be well above our average of 11%.
Understood. Regarding the second item, the $100 million debt reduction target for this year: first off, does that figure refer to gross debt reduction? And if so, secondly, which area are you aiming that reduction at? Could it be via the term loan, or perhaps by capturing some discount on the bonds?
Yeah. No, like you observed — thanks for asking, incidentally. Yeah. So, as you noticed during the quarter, we seized the opportunity to repurchase both bonds and the term loan on the open market. Therefore, we'll pursue whichever yield offers, in a sense, the optimal deployment of capital in terms of — and our purchases happen on the open market. So that's the method we'd use. It simply comes down to which delivers the greatest return at any particular moment as we deleverage across the year.
I've got two follow-ups, and hopefully they'll be quick ones. Curt, during your prepared remarks you brought up better operations along with platforms that were oversold. I'm simply wondering what exactly you meant by that, whether it's an area where you're limited on capacity or something along those lines in North America?
Yeah. Like we said — like I said previously on this call, whenever there's a spike — say a spike in flu season, you might get hit with a huge volume of orders over a brief window, and in that situation you'll push certain capacity levels to their limit if you happen to be near that 90% utilization mark. So our real focus is on a few of those platforms inside our system where the market isn't as oversupplied when you look at supply-demand dynamics, and that differs depending on the region, Gabe. Yet the goal, ideally, is to figure out how to get more product out of the assets we already have. That comes from operational excellence and productivity efforts, and supply chain factors into it too. So it means collaborating with our customers, figuring out which SKUs run best, how we can get the most from them; plus the effort the team has put into material science and material innovation, which has genuinely enabled us as we've worked to qualify alternative raw materials and locate more efficient material streams for our lines. And it might be something as straightforward — when we consider a few of our production lines, Gabe, it might be something as straightforward as upgrading an existing winder so the extrusion and the whole setup of running our lines faster, while keeping the same quality and service their customers anticipate, can deliver more throughput on those lines by putting the right technology at the end of the line to boost the machines' overall throughput.
Understood. All right, so it seems like this is comparatively light on capital. Two final questions that aren't connected. The first one is simply about seasonality. Clearly, we don't have much historical data with the merged company. Yet around the middle of the guidance range, I believe you've previously mentioned roughly low 40% in the first half, with the rest coming in the second half. Could either Jim or Curt help break that down for us? Then, to sharpen the point slightly on synergy achievement. I believe the end goal was $55 million. In the prior year, absolute realization was around the mid-teens. What is the objective for '26? And then what does that leave remaining for '27 that we need to pursue?
Thank you, Gabe. Regarding your second question, I think we've set $25 million of realized synergies for 2026, with the remainder then being worked through during '27; we can circle back on that, or Jim, you could emphasize it; and as for your first question, concerning demand quarter by quarter, once more, each region differs somewhat when it comes to summer months and holidays, and so on; however, broadly speaking, Q3, Q2, Q4, Q1 would represent the demand outlooks for us. Thus Q4 is somewhat softer owing to European shutdowns and, pardon me, our fiscal Q4, Gabe, while Q1 ranks among the softer quarters because of the holidays we observe, including Christmas, New Year's, Thanksgiving, and so forth, across North America. So that's Q3, Q2, Q4, Q1.
Appreciate it, operator, and I want to thank all of you for being on this call and for your interest in Magnera. Over the next several days, we're eager to reconnect with a lot of you, and we're also looking forward to the upcoming earnings call covering our Q3 or Q2 results. So thank you for taking part. Enjoy the rest of your day.
Thank you, everyone, for joining in. That brings today's session to an end, so you're welcome to leave the call now.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Magnera Corporation transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Magnera Corporation earnings transcripts and 132,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.